alexa Mesenchymal Stem Cells As A Therapeutic Option For Pati
ISSN: 2327-5146

General Medicine: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Mini Review

Mesenchymal Stem Cells As A Therapeutic Option For Patients With ALS

Dariusz Boruczkowski1, Dominika Gladysz1, Mariusz Grudniak1, Karol Kosterna1 and Katarzyna Pawelec1,2*

1Polish Stem Cells Bank, Warsaw, Poland

2Department of Pediatrics, Hematology and Oncology, Medical University of Warsaw, Poland

*Corresponding Author:
Katarzyna Pawelec
Department of Pediatrics, Hematology and Oncology Medical University of Warsaw
Zwirki I Wigury 63A, 02-091 Warszawa, Poland
Tel: +4822 22 317 96 21
Fax: +4822 22 317 96 21
E-mail: [email protected]

Received March 9, 2016 ; Accepted April 21, 2016; Published April 27, 2016

Citation: Boruczkowski D, Gladysz D, Grudniak M, Kosterna K, Pawelec K (2016) Mesenchymal Stem Cells As A Therapeutic Option For Patients With ALS. Gen Med (Los Angel) 4:235. doi:10.4172/2327-5146.1000235

Copyright: © 2016 Boruczkowski D, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



It has been postulated that mesenchymal stem cells could play a role in treatment of patients with amyotrophic lateral sclerosis. Variety of mechanism behind MSC action has been proposed including immunomodulation and delivery of trophic factors. The scientific rationale in preclinical studies is being proved along with first clinical uses. Recent advances in stem cell research rises new hope for patients with ALS.

Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version